Showing results (1121-1130 of 1,137) with videos related to

Sort By:
Pageof 114
Allergy|September 8, 2021
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2Mona O Mohsen, Ina Balke, Simon Zinkhan, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 22, 2024
Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical PracticeSilke Zachariae, Anne S Quante, Marion Kiechle, et al.
Journal of Medical Genetics|March 2, 2016
Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancerKarin Kast, Kerstin Rhiem, Barbara Wappenschmidt, et al.
International Journal of Cancer|May 14, 2019
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillanceChristoph Engel, Christine Fischer, Silke Zachariae, et al.
The American Journal of Gastroenterology|April 26, 2017
The Natural History of Severe Acute Liver InjuryDavid G Koch, J L Speiser, V Durkalski, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2026
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancerNatalie Herold, Christoph Engel, Dorothee Speiser, et al.
Pageof 114